Bausch Health to reaffirm FY2025 guidance at high end at JPM conference

Bausch Health Companies Inc.

Presentation at 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026 at 3:45 p.m. PT.
Management expects to reaffirm full year 2025 guidance at the higher end of the range for Bausch Health ex B+L.
No specific financial figures or updated guidance were disclosed in this filing.
Live webcast and replay available on investor relations website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.